Growth Stories

Medpace

Cincinnati, Ohio

Status: Realized

View Profile

Partnered with an experienced founder-led management team in the rapidly expanding clinical research industry to expand international capabilities and add new therapeutic areas leading to significant revenue and EBITDA growth and successful sale of the company in 2014

CCMP invested in Medpace, a global clinical research organization, in 2011. Medpace provides a complete suite of late stage clinical trial services to pharmaceutical, biotech and medical device companies.

Opportunity and Why CCMP

  • Long history of partnering with founder-led businesses
  • Growing outsourcing trend and rebound in R&D spend of pharmaceutical companies
  • Strong and sustainable leadership positions in core therapeutic areas with ability to grow through geographic and therapeutic expansion

Value Creation

  • Invested in capabilities, particularly in Europe and Asia, to enable the company to win larger global studies and projects in new therapeutic areas
  • Recruited therapeutic experts to develop capabilities in new areas such as central nervous system, infectious disease, respiratory and medical device
  • Added new independent directors with deep industry experience to the board

Results

  • Significant revenue and EBITDA growth and free cash flow generation during CCMP’s ownership
  • Successful sale of company in 2014